Targeting Obesity to Treat Heart Failure - With Preserved Ejection Fraction (HFpEF)

Could weight loss be the key to managing heart failure? In this episode of Diabetes Insights, we dive into the STEP-HFpEF trial, a groundbreaking study exploring the role of GLP-1 receptor agonists in heart failure with preserved ejection fraction (HFpEF). Host Vivienne Parry speaks with Prof. Melanie Davies (University of Leicester), Prof. Mark Petrie (University of Glasgow), and Prof. Mikhail Kosiborod (Saint Luke’s Mid America Heart Institute, USA) about the link between obesity, diabetes, and HFpEF, and how weight management could transform heart failure treatment. With trials already in motion to explore prevention, could we stop HFpEF before it starts? Join us for this insightful conversation on targeting obesity to treat heart failure.